Skip to main content
Clinical Trials/JPRN-UMIN000035047
JPRN-UMIN000035047Completed未知

Clinical investigation of ninjin'yoeito for psychiatric symptoms and physical frailty among patients with mild cognitive impairment and Alzheimer's disease. - Effect of ninjin'yoeito among patients with mild cognitive impairment and Alzheimer's disease.

ational Center Geriatrics and Gerontology0 sites10 target enrollmentStarted: November 28, 2018Last updated:

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
10

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
65years-old to 89years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) Patients who have been taken other kampo medicines in the past month. 2) Patients who have MMSE score of 10 points or less. 3) Patients who switched or newly started using anti-dementia medications within 3 months from the start of the survey. 4) Patients who have been taking sweetroot-containing drug and/or glycyrrhizinate-containing drug. 5) Patients who switched or newly started using antipsychotic medications within 3 months from the start of the survey. 6) Patients who have mental disorders caused by cerebrovascular disorders, head injuries, brain tumors, or encephalitis. 7) Patients whom investigators consider to be ineligible.

Investigators

Sponsor
ational Center Geriatrics and Gerontology

Similar Trials